Immunohistochemical Phenotyping of Plasma Cells in Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia is Comparable to Flow Cytometric Techniques-Reference-Cited by-同舟云学术

Immunohistochemical Phenotyping of Plasma Cells in Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia is Comparable to Flow Cytometric Techniques

Published:2011-02 Issue:1 Volume:11 Page:96-98
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Howard Matthew T.,Hodnefield Janice,Morice William G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference7 articles.

1. A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma;de Tute;Leukemia,2007

2. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom's macroglobulinemia;Morice;Mod Pathol,2009

3. Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders;Morice;Leukemia,2007

4. Immunophenotypic analysis of Waldenstrom's macroglobulinemia;San Miguel;Sem Oncology,2003

5. Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry;Kurtin;Am J Clin Path,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia;iScience;2022-08

2. Flow Cytometric Immunophenotypic Analysis in the Diagnosis and Prognostication of Plasma Cell Neoplasms;Cytometry Part B: Clinical Cytometry;2019-09

3. Role of plasma cells in Waldenström macroglobulinaemia;Pathology;2017-06

4. Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group;Internal Medicine Journal;2017-01

5. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May HarborMYD88L265P Mutations;American Journal of Clinical Pathology;2016-06